Literature DB >> 9880548

Conformational changes in rhodopsin. Movement of helix f detected by site-specific chemical labeling and fluorescence spectroscopy.

T D Dunham1, D L Farrens.   

Abstract

A recent proposal for the formation of functionally active rhodopsin has placed critical importance on a movement of one of its transmembrane helices (Farrens, D. L., Altenbach, C., Yang, K., Hubbell, W. L., and Khorana, H. G. (1996) Science 274, 768-770). We investigated this hypothesis using a series of eight rhodopsin mutants containing single reactive cysteine residues in the region (helix F) where movement was previously detected. The cysteine mutants were studied in two ways, by measuring their reactivity to a cysteine-specific reagent (PyMPO-maleimide), and by labeling the cysteines with a fluorescent label (monobromobimane) followed by fluorescence spectroscopic analysis. The chemical reactivity data showed sequence-specific variations in reactivity for the mutants in the dark state, resulting in a pattern suggestive of an alpha helix. Interestingly, only upon photoactivation to the MII form did residues found on the inner "face" of this helix react with the PyMPO-maleimide. The ability of the dark state mutants to react with the fluorescent label monobromobimane followed a similar pattern. Furthermore, fluorescence measurements indicate that a bimane label on the inner face of the helix (at V250C) detects changes in the polarity of its environment and accessibility to a fluorescence quenching agent upon MII formation. Viewed together, the data provide further direct evidence that rhodopsin activation involves a conformational change at helix F.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9880548     DOI: 10.1074/jbc.274.3.1683

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor.

Authors:  Zhan-Guo Gao; Aishe Chen; Dov Barak; Soo-Kyung Kim; Christa E Müller; Kenneth A Jacobson
Journal:  J Biol Chem       Date:  2002-03-12       Impact factor: 5.157

2.  Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor.

Authors:  P Ghanouni; J J Steenhuis; D L Farrens; B K Kobilka
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

3.  Structural insights into human GPCR protein OA1: a computational perspective.

Authors:  Anirban Ghosh; Uddhavesh Sonavane; Sai Krishna Andhirka; Gopala Krishna Aradhyam; Rajendra Joshi
Journal:  J Mol Model       Date:  2011-09-22       Impact factor: 1.810

Review 4.  G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin.

Authors:  J Ballesteros; K Palczewski
Journal:  Curr Opin Drug Discov Devel       Date:  2001-09

Review 5.  Homology modeling of opioid receptor-ligand complexes using experimental constraints.

Authors:  Irina D Pogozheva; Magdalena J Przydzial; Henry I Mosberg
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

Review 6.  G protein coupled receptor structure and activation.

Authors:  Brian K Kobilka
Journal:  Biochim Biophys Acta       Date:  2006-11-15

7.  SPECTRAL METHODS FOR STUDY OF THE G-PROTEIN-COUPLED RECEPTOR RHODOPSIN. I. VIBRATIONAL AND ELECTRONIC SPECTROSCOPY.

Authors:  A V Struts; A V Barmasov; M F Brown
Journal:  Opt Spectrosc       Date:  2015-05-27       Impact factor: 0.891

8.  Influence of oligomerization on the dynamics of G-protein coupled receptors as assessed by normal mode analysis.

Authors:  Masha Y Niv; Marta Filizola
Journal:  Proteins       Date:  2008-05-01

9.  Influence of Arrestin on the Photodecay of Bovine Rhodopsin.

Authors:  Deep Chatterjee; Carl Elias Eckert; Chavdar Slavov; Krishna Saxena; Boris Fürtig; Charles R Sanders; Vsevolod V Gurevich; Josef Wachtveitl; Harald Schwalbe
Journal:  Angew Chem Int Ed Engl       Date:  2015-09-18       Impact factor: 15.336

10.  The fifth transmembrane domain of angiotensin II Type 1 receptor participates in the formation of the ligand-binding pocket and undergoes a counterclockwise rotation upon receptor activation.

Authors:  Ivana Domazet; Stéphane S Martin; Brian J Holleran; Marie-Eve Morin; Patrick Lacasse; Pierre Lavigne; Emanuel Escher; Richard Leduc; Gaétan Guillemette
Journal:  J Biol Chem       Date:  2009-09-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.